Bausch Health Companies (BHC) Interest Expenses (2009 - 2026)
Bausch Health Companies (BHC) posted Interest Expenses of $2.8 billion for Q2 2026, up 3.38% sequentially from $2.7 billion in Q1 2026, and up 499.35% YoY from $465.0 million in Q2 2025.
Bausch Health Companies (BHC) Interest Expenses (2009 - 2026) Analysis & Trends
Bausch Health Companies has reported Interest Expenses for 18 years, with the latest figure at $2.8 billion in Q2 2026.
- Quarterly Interest Expenses rose 499.35% year-over-year to $2.8 billion in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $2.8 billion (up 65.01% YoY) and the FY2025 annual result came in at $2.6 billion, up 12.78% from the prior year.
- Interest Expenses advanced to $2.8 billion in Q2 2026 per BHC's latest filing, from $2.7 billion in the prior quarter.
- Over five years, Interest Expenses peaked at $2.8 billion in Q2 2026 and troughed at $307.0 million in Q4 2022.
- A 5-year average of $871.2 million and a median of $554.0 million in 2023 frame the typical range for Interest Expenses.
- The sharpest annual moves came in 2023 and 2026: Interest Expenses slumped 51.96% in 2023, then jumped 618.93% in 2026.
- Over 5 years, Interest Expenses stood at $307.0 million in 2022, then jumped by 85.02% to $568.0 million in 2023, then slumped by 40.67% to $337.0 million in 2024, then increased by 17.8% to $397.0 million in 2025, then soared by 602.02% to $2.8 billion in 2026.
- According to Business Quant data, Interest Expenses over the past three periods registered $2.8 billion, $2.7 billion, and $397.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | -400.56 Mn |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn | 2.90 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 120.70 Mn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 2.90 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 59.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | - |
| 10 | Bausch Health Companies | 2.57 Bn | 732.63 Mn | 2.10 Bn | 396.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.79 Bn |
| Jun 30, 2026 | 2.79 Bn |
| Mar 31, 2026 | -552.00 Mn |
| Mar 31, 2026 | -552.00 Mn |
| Dec 31, 2025 | 397.00 Mn |
| Dec 31, 2025 | 397.00 Mn |
| Sep 30, 2025 | 412.00 Mn |
| Sep 30, 2025 | 412.00 Mn |
| Jun 30, 2025 | 2.37 Bn |
| Jun 30, 2025 | 2.37 Bn |
| Mar 31, 2025 | 330.00 Mn |
| Mar 31, 2025 | 330.00 Mn |
| Dec 31, 2024 | 337.00 Mn |
| Dec 31, 2024 | 337.00 Mn |
| Sep 30, 2024 | 346.00 Mn |
| Sep 30, 2024 | 346.00 Mn |
| Jun 30, 2024 | 532.00 Mn |
| Jun 30, 2024 | 532.00 Mn |
| Mar 31, 2024 | 355.00 Mn |
| Mar 31, 2024 | 355.00 Mn |